- |||||||||| ivermectin oral / Generic mfg.
Enrollment change, Trial completion date, Trial initiation date, Trial primary completion date, Combination therapy: SINZ-COVID-PK: Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients (clinicaltrials.gov) - Jan 22, 2021 P1/2, N=60, Recruiting, N=40 --> 60 | Trial completion date: Sep 2020 --> Oct 2021 | Initiation date: Jul 2020 --> Nov 2020 | Trial primary completion date: Sep 2020 --> Aug 2021
- |||||||||| Actemra IV (tocilizumab) / Roche, JW Pharma, Soliris (eculizumab) / Alexion Pharma
Clinical, Journal: Evaluation of the initial response in clinical trial efforts for COVID-19 in Brazil. (Pubmed Central) - Jan 21, 2021 The interventions evaluated during the Brazilian research response reflect those of international initiatives, but with a different distribution and a large number of studies assessing hydroxychloroquine/chloroquine. Limitations in methodological design and sample planning represent challenges that could affect the research outreach.
|